• Home
  • >
  • Zim Laboratories Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/zim-laboratories-ltd.png Logo

Zim Laboratories Ltd Financial Statement

Zim Laboratories Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue118.9296.9386.68
Operating Expense101.9684.6476.3
Net Profit7.894.834.18
Net Profit Margin6.634.984.82
Earning Per Share1.620.990.86
EBIDTA12.7511.419.94
Effective Tax Rate-7.6110.597.9

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Zim Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual398.53333.43307.26
Operating Expenses Annual346.54292.45267.5
Operating Profit Annual58.445.3836.92
Interest Annual5.588.3110.9
Depreciation13.4712.912.74
Net Profit Annual24.4314.557.32
Tax Annual10.926.492.91

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Zim Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning3.421.391.46
Cash Flow from Operations37.5249.2131.85
Cash Flow from Investing-35.06-14.21-5.95
Cash Flow from Financing0.55-32.97-25.97
Cash Flow at the End6.423.421.39

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Zim Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)14.6513.6113.7
PBIT Margin (%)10.278.818.56
PBT Margin (%)8.427.747.77
Net PROFIT Margin (%)6.313.951.85
Return On Networth / Equity (%)12.998.657.01
Return On Networth /Employed(%)16.6512.4310.8
Return On Assets (%)10.225.572.33
Total Debt / Equity(X)0.320.410.56
Asset Turnover Ratio (%)1.621.411.26

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Zim Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual117.81112.29112.64
Total Current Assets Annual190.95212.14191.76
Non Current Assets Annual150.63129.49133.02
Total Shareholders Funds Annual200.35175.71160.75
Total Assets Annual341.58341.63324.78

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Zim Laboratories Ltd Earning Calls
Mar 2024
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Zim Laboratories Ltd has a market capitalization of 465.33 Cr. Value Research classifies it as a Small-Cap company.

Yes, Zim Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.46.

In FY 2023, Zim Laboratories Ltd recorded a total revenue of approximately 367.42 Cr marking a significant milestone in the company's financial performance.

Zim Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.0% annually, respectively..

Zim Laboratories Ltd's current PE ratio is 26.98.

Zim Laboratories Ltd's ROCE averaged 12.4% from the FY ending March 2022 to 2024, with a median of 12.8%. It peaked at 15.6% in March 2023, reflecting strong capital efficiency over the period..

Zim Laboratories Ltd's latest EBIT is Rs. 30.56 Cr, surpassing the average EBIT of Rs. 33.62 Cr over the 5 years..